Long-term outcomes of high-dose-rate brachytherapy and external beam radiotherapy without hormone therapy for high-risk localized prostate cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Long-term outcomes of high-dose-rate brachytherapy and external beam radiotherapy without hormone therapy for high-risk localized prostate cancer ; day:29 ; month:6 ; year:2024 ; pages:1-8
Japanese journal of radiology ; (29.6.2024), 1-8
- Urheber
-
Kamitani, Nobuhiko
Watanabe, Kenta
Ikeda, Naoki
Kawata, Yujiro
Tokiya, Ryoji
Hayashi, Takafumi
Miyaji, Yoshiyuki
Tamada, Tsutomu
Katsui, Kuniaki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11604-024-01621-4
- URN
-
urn:nbn:de:101:1-2409201051186.825623200858
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kamitani, Nobuhiko
- Watanabe, Kenta
- Ikeda, Naoki
- Kawata, Yujiro
- Tokiya, Ryoji
- Hayashi, Takafumi
- Miyaji, Yoshiyuki
- Tamada, Tsutomu
- Katsui, Kuniaki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study
Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer
High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis
Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Stereotacticbody radiotherapy for high-risk prostate cancer: a systematic review
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost
After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study
Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer
High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis
Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Stereotacticbody radiotherapy for high-risk prostate cancer: a systematic review
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost
After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study
Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer
High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis
Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Stereotacticbody radiotherapy for high-risk prostate cancer: a systematic review
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost